VIAF

Virtual International Authority File

Search

Leader 00000nz a2200037n 45 0
001 WKP|Q51679770 (VIAF cluster) (Authority/Source Record)
003 WKP
005 20241221010721.0
008 241221nneanz||abbn n and d
035 ‎‡a (WKP)Q51679770‏
024 ‎‡a 0000-0001-8837-4928‏ ‎‡2 orcid‏
024 ‎‡a 26665749300‏ ‎‡2 scopus‏
035 ‎‡a (OCoLC)Q51679770‏
100 0 ‎‡a Jaclyn A. Smith‏ ‎‡c researcher‏ ‎‡9 en‏
400 0 ‎‡a Jaclyn A Smith‏ ‎‡c wetenschapper‏ ‎‡9 nl‏
670 ‎‡a Author's 17q12-21 variants are associated with asthma and interact with active smoking in an adult population from the United Kingdom‏
670 ‎‡a Author's A causal relationship between cough and gastroesophageal reflux disease (GERD) has been established: a pro/con debate‏
670 ‎‡a Author's A comparison of objective and subjective measures of cough in asthma‏
670 ‎‡a Author's A novel approach to studying the relationship between subjective and objective measures of cough.‏
670 ‎‡a Author's A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response‏
670 ‎‡a Author's Ambulatory methods for recording cough.‏
670 ‎‡a Author's An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses‏
670 ‎‡a Author's Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report‏
670 ‎‡a Author's Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease.‏
670 ‎‡a Author's Antitussive drugs--past, present, and future‏
670 ‎‡a Author's Antitussive effects of memantine in guinea pigs.‏
670 ‎‡a Author's Applying Best–Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer‏
670 ‎‡a Author's Aprepitant For Cough in Lung Cancer: A Randomised Placebo-Controlled Trial and Mechanistic Insights‏
670 ‎‡a Author's Assessing efficacy of therapy for cough.‏
670 ‎‡a Author's Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report‏
670 ‎‡a Author's Bedside ultrasound of the neck confirms endotracheal tube position in emergency intubations‏
670 ‎‡a Author's Branching Out in Chronic Cough; Evidence for Increased Airway Nerve Density‏
670 ‎‡a Author's Breaking the sound barrier? Pitfalls and benefits of acoustic cough monitoring.‏
670 ‎‡a Author's Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma.‏
670 ‎‡a Author's Breathing hot humid air induces airway irritation and cough in patients with allergic rhinitis.‏
670 ‎‡a Author's Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunction‏
670 ‎‡a Author's Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough‏
670 ‎‡a Author's Clinical features of the urge-to-cough in patients with chronic cough‏
670 ‎‡a Author's Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionals‏
670 ‎‡a Author's Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers‏
670 ‎‡a Author's COPD phenotype description using principal components analysis‏
670 ‎‡a Author's Cough and its importance in COPD‏
670 ‎‡a Author's Cough frequency and patterns of cough in cystic fibrosis‏
670 ‎‡a Author's Cough hypersensitivity syndrome: clinical measurement is the key to progress‏
670 ‎‡a Author's Cough in chronic obstructive pulmonary disease.‏
670 ‎‡a Author's Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments.‏
670 ‎‡a Author's Data reduction for cough studies using distribution of audio frequency content‏
670 ‎‡a Author's Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough‏
670 ‎‡a Author's Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale‏
670 ‎‡a Author's Dimensions of respiratory symptoms in preschool children: population-based birth cohort study‏
670 ‎‡a Author's Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease‏
670 ‎‡a Author's ERS guidelines on the assessment of cough‏
670 ‎‡a Author's Expert opinion on the cough hypersensitivity syndrome in respiratory medicine.‏
670 ‎‡a Author's Gabapentin for refractory chronic cough‏
670 ‎‡a Author's Gastro-oesophageal reflux and cough‏
670 ‎‡a Author's Gefapixant in two randomised dose-escalation studies in chronic cough‏
670 ‎‡a Author's GERD-related cough: pathophysiology and diagnostic approach.‏
670 ‎‡a Author's High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease‏
670 ‎‡a Author's How to quantify coughing: correlations with quality of life in chronic cough‏
670 ‎‡a Author's Interrupting the cough reflex in asthma‏
670 ‎‡a Author's Interventions for cough in cancer‏
670 ‎‡a Author's Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial‏
670 ‎‡a Author's Monitoring chronic cough: current and future techniques‏
670 ‎‡a Author's Morphologic Characterization of Nerves in Whole-Mount Airway Biopsies‏
670 ‎‡a Author's Muscle activation and sound during voluntary single coughs and cough peals in healthy volunteers: Insights into cough intensity.‏
670 ‎‡a Author's Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies.‏
670 ‎‡a Author's New developments in reflux-associated cough.‏
670 ‎‡a Author's New developments in the objective assessment of cough.‏
670 ‎‡a Author's New insights in cough.‏
670 ‎‡a Author's Objective Cough Frequency, Airway Inflammation, and Disease Control in Asthma.‏
670 ‎‡a Author's Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis.‏
670 ‎‡a Author's Objective measurement of cough in otherwise healthy volunteers with acute cough.‏
670 ‎‡a Author's P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.‏
670 ‎‡a Author's P2X3 receptor antagonist in chronic cough--Authors' reply.‏
670 ‎‡a Author's Patient Misreporting May Lead to Underestimation of Cough Events‏
670 ‎‡a Author's PCR based bronchoscopic detection of common respiratory pathogens in chronic cough: a case control study‏
670 ‎‡a Author's Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection.‏
670 ‎‡a Author's Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point.‏
670 ‎‡a Author's Pharmacologic therapy for cough‏
670 ‎‡a Author's Predictors of objective cough frequency in chronic obstructive pulmonary disease‏
670 ‎‡a Author's Qualitative aspects of breathlessness in health and disease.‏
670 ‎‡a Author's Quality of life in patients with chronic cough.‏
670 ‎‡a Author's Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis‏
670 ‎‡a Author's Respiratory disease and the oesophagus: reflux, reflexes and microaspiration‏
670 ‎‡a Author's Sex differences and predictors of objective cough frequency in chronic cough.‏
670 ‎‡a Author's Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel Report‏
670 ‎‡a Author's Taming chronic cough‏
670 ‎‡a Author's Targeting TRP channels for chronic cough: from bench to bedside.‏
670 ‎‡a Author's The description of cough sounds by healthcare professionals‏
670 ‎‡a Author's The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study‏
670 ‎‡a Author's The effect of gas standardisation on exhaled breath condensate pH‏
670 ‎‡a Author's The effect of mindfulness meditation on cough reflex sensitivity.‏
670 ‎‡a Author's The efficacy of a NOP1 agonist‏
670 ‎‡a Author's The efficacy of a NOP1 agonist (SCH486757) in subacute cough.‏
670 ‎‡a Author's The interaction between bronchoconstriction and cough in asthma.‏
670 ‎‡a Author's The Leicester Cough Monitor: a semi-automated, semi-validated cough detection system?‏
670 ‎‡a Author's The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool‏
670 ‎‡a Author's The oesophagus and cough: laryngo-pharyngeal reflux, microaspiration and vagal reflexes‏
670 ‎‡a Author's Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report‏
670 ‎‡a Author's Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate‏
670 ‎‡a Author's Transient receptor potential vanilloid 1‏
670 ‎‡a Author's Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.‏
670 ‎‡a Author's Weak peristalsis with large breaks in chronic cough: association with poor esophageal clearance.‏
670 ‎‡a Author's XEN-D0501, a Novel TRPV1 Antagonist, Does Not Reduce Cough in Refractory Cough Patients.‏
909 ‎‡a (scopus) 26665749300‏ ‎‡9 1‏
909 ‎‡a (orcid) 0000000188374928‏ ‎‡9 1‏
919 ‎‡a effectofcodeineonobjectivemeasurementofcoughinchronicobstructivepulmonarydisease‏ ‎‡A Effect of codeine on objective measurement of cough in chronic obstructive pulmonary disease‏ ‎‡9 1‏
919 ‎‡a neurophenotypesinairwaydiseasesinsightsfromtranslationalcoughstudies‏ ‎‡A Neurophenotypes in Airway Diseases. Insights from Translational Cough Studies.‏ ‎‡9 1‏
919 ‎‡a dimensionsofrespiratorysymptomsinpreschoolchildrenpopulationbasedbirthcohortstudy‏ ‎‡A Dimensions of respiratory symptoms in preschool children: population-based birth cohort study‏ ‎‡9 1‏
919 ‎‡a newdevelopmentsinrefluxassociatedcough‏ ‎‡A New developments in reflux-associated cough.‏ ‎‡9 1‏
919 ‎‡a newdevelopmentsintheobjectiveassessmentofcough‏ ‎‡A New developments in the objective assessment of cough.‏ ‎‡9 1‏
919 ‎‡a newinsightsincough‏ ‎‡A New insights in cough.‏ ‎‡9 1‏
919 ‎‡a objectivecoughfrequencyairwayinflammationanddiseasecontrolinasthma‏ ‎‡A Objective Cough Frequency, Airway Inflammation, and Disease Control in Asthma.‏ ‎‡9 1‏
919 ‎‡a objectivemeasurementofcoughduringpulmonaryexacerbationsinadultswithcysticfibrosis‏ ‎‡A Objective measurement of cough during pulmonary exacerbations in adults with cystic fibrosis.‏ ‎‡9 1‏
919 ‎‡a objectivemeasurementofcoughinotherwisehealthyvolunteerswithacutecough‏ ‎‡A Objective measurement of cough in otherwise healthy volunteers with acute cough.‏ ‎‡9 1‏
919 ‎‡a p2x3receptorantagonistaf219inrefractorychroniccougharandomiseddoubleblindplacebocontrolledphase2study‏ ‎‡A P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study.‏ ‎‡9 1‏
919 ‎‡a p2x3receptorantagonistinchroniccoughauthorsreply‏ ‎‡A P2X3 receptor antagonist in chronic cough--Authors' reply.‏ ‎‡9 1‏
919 ‎‡a developmentdimensionsreliabilityandvalidityofthenovelmanchestercopdfatiguescale‏ ‎‡A Development, dimensions, reliability and validity of the novel Manchester COPD fatigue scale‏ ‎‡9 1‏
919 ‎‡a designandrationaleof2phase3randomisedcontrolledtrialscough1andcough2ofgefapixantap2x3receptorantagonistinrefractoryorunexplainedchroniccough‏ ‎‡A Design and rationale of two phase 3 randomised controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough‏ ‎‡9 1‏
919 ‎‡a datareductionforcoughstudiesusingdistributionofaudiofrequencycontent‏ ‎‡A Data reduction for cough studies using distribution of audio frequency content‏ ‎‡9 1‏
919 ‎‡a coughincopdcorrelationofobjectivemonitoringwithcoughchallengeandsubjectiveassessments‏ ‎‡A Cough in COPD: correlation of objective monitoring with cough challenge and subjective assessments.‏ ‎‡9 1‏
919 ‎‡a coughinchronicobstructivepulmonarydisease‏ ‎‡A Cough in chronic obstructive pulmonary disease.‏ ‎‡9 1‏
919 ‎‡a coughhypersensitivitysyndromeclinicalmeasurementisthekeytoprogress‏ ‎‡A Cough hypersensitivity syndrome: clinical measurement is the key to progress‏ ‎‡9 1‏
919 ‎‡a coughanditsimportanceincopd‏ ‎‡A Cough and its importance in COPD‏ ‎‡9 1‏
919 ‎‡a copdphenotypedescriptionusingprincipalcomponentsanalysis‏ ‎‡A COPD phenotype description using principal components analysis‏ ‎‡9 1‏
919 ‎‡a considerationsindevelopinganddeliveringanonpharmacologicalinterventionforsymptommanagementinlungcancertheviewsofpatientsandinformalcaregivers‏ ‎‡A Considerations in developing and delivering a nonpharmacological intervention for symptom management in lung cancer: the views of patients and informal caregivers‏ ‎‡9 1‏
919 ‎‡a considerationsindevelopinganddeliveringanonpharmacologicalinterventionforsymptommanagementinlungcancertheviewsofhealthcareprofessionals‏ ‎‡A Considerations in developing and delivering a non-pharmacological intervention for symptom management in lung cancer: the views of health care professionals‏ ‎‡9 1‏
919 ‎‡a clinicalfeaturesoftheurgetocoughinpatientswithchroniccough‏ ‎‡A Clinical features of the urge-to-cough in patients with chronic cough‏ ‎‡9 1‏
919 ‎‡a clinicalexpertguidelinesforthemanagementofcoughinlungcancerreportofauktaskgrouponcough‏ ‎‡A Clinical expert guidelines for the management of cough in lung cancer: report of a UK task group on cough‏ ‎‡9 1‏
919 ‎‡a capsaicinevokedcoughresponsesinasthmaticpatientsevidenceforairwayneuronaldysfunction‏ ‎‡A Capsaicin-evoked cough responses in asthmatic patients: Evidence for airway neuronal dysfunction‏ ‎‡9 1‏
919 ‎‡a breathinghothumidairinducesairwayirritationandcoughinpatientswithallergicrhinitis‏ ‎‡A Breathing hot humid air induces airway irritation and cough in patients with allergic rhinitis.‏ ‎‡9 1‏
919 ‎‡a breathmetabolomicprofilingbynuclearmagneticresonancespectroscopyinasthma‏ ‎‡A Breath metabolomic profiling by nuclear magnetic resonance spectroscopy in asthma.‏ ‎‡9 1‏
919 ‎‡a breakingthesoundbarrierpitfallsandbenefitsofacousticcoughmonitoring‏ ‎‡A Breaking the sound barrier? Pitfalls and benefits of acoustic cough monitoring.‏ ‎‡9 1‏
919 ‎‡a branchingoutinchroniccoughevidenceforincreasedairwaynervedensity‏ ‎‡A Branching Out in Chronic Cough; Evidence for Increased Airway Nerve Density‏ ‎‡9 1‏
919 ‎‡a patientmisreportingmayleadtounderestimationofcoughevents‏ ‎‡A Patient Misreporting May Lead to Underestimation of Cough Events‏ ‎‡9 1‏
919 ‎‡a bedsideultrasoundoftheneckconfirmsendotrachealtubepositioninemergencyintubations‏ ‎‡A Bedside ultrasound of the neck confirms endotracheal tube position in emergency intubations‏ ‎‡9 1‏
919 ‎‡a pcrbasedbronchoscopicdetectionofcommonrespiratorypathogensinchroniccoughacasecontrolstudy‏ ‎‡A PCR based bronchoscopic detection of common respiratory pathogens in chronic cough: a case control study‏ ‎‡9 1‏
919 ‎‡a pepsinabiomarkerofgastricaspirationinlungallograftsaputativeassociationwithrejection‏ ‎‡A Pepsin, a biomarker of gastric aspiration in lung allografts: a putative association with rejection.‏ ‎‡9 1‏
919 ‎‡a assessmentofinterventionfidelityandrecommendationsforresearchersconductingstudiesonthediagnosisandtreatmentofchroniccoughintheadultchestguidelineandexpertpanelreport‏ ‎‡A Assessment of Intervention Fidelity and Recommendations for Researchers Conducting Studies on the Diagnosis and Treatment of Chronic Cough in the Adult: CHEST Guideline and Expert Panel Report‏ ‎‡9 1‏
919 ‎‡a pharmacodynamicmodelingofcoughresponsestocapsaicininhalationcallsintoquestiontheutilityofthec5endpoint‏ ‎‡A Pharmacodynamic modeling of cough responses to capsaicin inhalation calls into question the utility of the C5 end point.‏ ‎‡9 1‏
919 ‎‡a pharmacologictherapyforcough‏ ‎‡A Pharmacologic therapy for cough‏ ‎‡9 1‏
919 ‎‡a assessingefficacyoftherapyforcough‏ ‎‡A Assessing efficacy of therapy for cough.‏ ‎‡9 1‏
919 ‎‡a predictorsofobjectivecoughfrequencyinchronicobstructivepulmonarydisease‏ ‎‡A Predictors of objective cough frequency in chronic obstructive pulmonary disease‏ ‎‡9 1‏
919 ‎‡a qualitativeaspectsofbreathlessnessinhealthanddisease‏ ‎‡A Qualitative aspects of breathlessness in health and disease.‏ ‎‡9 1‏
919 ‎‡a aprepitantforcoughinlungcancerarandomisedplacebocontrolledtrialandmechanisticinsights‏ ‎‡A Aprepitant For Cough in Lung Cancer: A Randomised Placebo-Controlled Trial and Mechanistic Insights‏ ‎‡9 1‏
919 ‎‡a qualityoflifeinpatientswithchroniccough‏ ‎‡A Quality of life in patients with chronic cough.‏ ‎‡9 1‏
919 ‎‡a randomiseddoubleblindplacebocontrolledpilottrialofomeprazoleinidiopathicpulmonaryfibrosis‏ ‎‡A Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis‏ ‎‡9 1‏
919 ‎‡a applyingbestworstscalingmethodologytoestablishdeliverypreferencesofasymptomsupportivecareinterventioninpatientswithlungcancer‏ ‎‡A Applying Best–Worst scaling methodology to establish delivery preferences of a symptom supportive care intervention in patients with lung cancer‏ ‎‡9 1‏
919 ‎‡a respiratorydiseaseandtheoesophagusrefluxreflexesandmicroaspiration‏ ‎‡A Respiratory disease and the oesophagus: reflux, reflexes and microaspiration‏ ‎‡9 1‏
919 ‎‡a antitussiveeffectsofmemantineinguineapigs‏ ‎‡A Antitussive effects of memantine in guinea pigs.‏ ‎‡9 1‏
919 ‎‡a antitussivedrugspastpresentandfuture‏ ‎‡A Antitussive drugs--past, present, and future‏ ‎‡9 1‏
919 ‎‡a antibioticuseinpatientsadmittedwithacuteexacerbationsofchronicobstructivepulmonarydisease‏ ‎‡A Antibiotic use in patients admitted with acute exacerbations of chronic obstructive pulmonary disease.‏ ‎‡9 1‏
919 ‎‡a anatomyandneurophysiologyofcoughchestguidelineandexpertpanelreport‏ ‎‡A Anatomy and neurophysiology of cough: CHEST Guideline and Expert Panel report‏ ‎‡9 1‏
919 ‎‡a integrativereviewofsystematicreviewsrelatedtothemanagementofbreathlessnessinrespiratoryillnesses‏ ‎‡A An integrative review of systematic reviews related to the management of breathlessness in respiratory illnesses‏ ‎‡9 1‏
919 ‎‡a ambulatorymethodsforrecordingcough‏ ‎‡A Ambulatory methods for recording cough.‏ ‎‡9 1‏
919 ‎‡a worldwidesurveyofchroniccoughamanifestationofenhancedsomatosensoryresponse‏ ‎‡A A worldwide survey of chronic cough: a manifestation of enhanced somatosensory response‏ ‎‡9 1‏
919 ‎‡a novelapproachtostudyingtherelationshipbetweensubjectiveandobjectivemeasuresofcough‏ ‎‡A A novel approach to studying the relationship between subjective and objective measures of cough.‏ ‎‡9 1‏
919 ‎‡a comparisonofobjectiveandsubjectivemeasuresofcoughinasthma‏ ‎‡A A comparison of objective and subjective measures of cough in asthma‏ ‎‡9 1‏
919 ‎‡a causalrelationshipbetweencoughandgastroesophagealrefluxdiseasegerdhasbeenestablishedaprocondebate‏ ‎‡A A causal relationship between cough and gastroesophageal reflux disease (GERD) has been established: a pro/con debate‏ ‎‡9 1‏
919 ‎‡a 17q1221variantsareassociatedwithasthmaandinteractwithactivesmokinginanadultpopulationfromtheunitedkingdom‏ ‎‡A 17q12-21 variants are associated with asthma and interact with active smoking in an adult population from the United Kingdom‏ ‎‡9 1‏
919 ‎‡a sexdifferencesandpredictorsofobjectivecoughfrequencyinchroniccough‏ ‎‡A Sex differences and predictors of objective cough frequency in chronic cough.‏ ‎‡9 1‏
919 ‎‡a somaticcoughsyndromepreviouslyreferredtoaspsychogeniccoughandticcoughpreviouslyreferredtoashabitcoughinadultsandchildrenchestguidelineandexpertpanelreport‏ ‎‡A Somatic Cough Syndrome (Previously Referred to as Psychogenic Cough) and Tic Cough (Previously Referred to as Habit Cough) in Adults and Children: CHEST Guideline and Expert Panel Report‏ ‎‡9 1‏
919 ‎‡a tamingchroniccough‏ ‎‡A Taming chronic cough‏ ‎‡9 1‏
919 ‎‡a targetingtrpchannelsforchroniccoughfrombenchtobedside‏ ‎‡A Targeting TRP channels for chronic cough: from bench to bedside.‏ ‎‡9 1‏
919 ‎‡a descriptionofcoughsoundsbyhealthcareprofessionals‏ ‎‡A The description of cough sounds by healthcare professionals‏ ‎‡9 1‏
919 ‎‡a effectofaclidiniumonsymptomsincludingcoughinchronicobstructivepulmonarydiseaseaphase4doubleblindplacebocontrolledparallelgroupstudy‏ ‎‡A The Effect of Aclidinium on Symptoms Including Cough in Chronic Obstructive Pulmonary Disease: A Phase 4, Double-Blind, Placebo-controlled, Parallel-Group Study‏ ‎‡9 1‏
919 ‎‡a effectofgasstandardisationonexhaledbreathcondensateph‏ ‎‡A The effect of gas standardisation on exhaled breath condensate pH‏ ‎‡9 1‏
919 ‎‡a effectofmindfulnessmeditationoncoughreflexsensitivity‏ ‎‡A The effect of mindfulness meditation on cough reflex sensitivity.‏ ‎‡9 1‏
919 ‎‡a efficacyofanop1agonist‏ ‎‡A The efficacy of a NOP1 agonist‏ ‎‡9 1‏
919 ‎‡a efficacyofanop1agonistsch486757insubacutecough‏ ‎‡A The efficacy of a NOP1 agonist (SCH486757) in subacute cough.‏ ‎‡9 1‏
919 ‎‡a interactionbetweenbronchoconstrictionandcoughinasthma‏ ‎‡A The interaction between bronchoconstriction and cough in asthma.‏ ‎‡9 1‏
919 ‎‡a leicestercoughmonitorasemiautomatedsemivalidatedcoughdetectionsystem‏ ‎‡A The Leicester Cough Monitor: a semi-automated, semi-validated cough detection system?‏ ‎‡9 1‏
919 ‎‡a manchestercoughinlungcancerscalethedevelopmentandpreliminaryvalidationofanewassessmenttool‏ ‎‡A The Manchester cough in lung cancer scale: the development and preliminary validation of a new assessment tool‏ ‎‡9 1‏
919 ‎‡a oesophagusandcoughlaryngopharyngealrefluxmicroaspirationandvagalreflexes‏ ‎‡A The oesophagus and cough: laryngo-pharyngeal reflux, microaspiration and vagal reflexes‏ ‎‡9 1‏
919 ‎‡a toolsforassessingoutcomesinstudiesofchroniccoughchestguidelineandexpertpanelreport‏ ‎‡A Tools for assessing outcomes in studies of chronic cough: CHEST guideline and expert panel report‏ ‎‡9 1‏
919 ‎‡a transientreceptorpotentialcationchannelsubfamily5member4andairwaysensoryafferentactivationroleofadenosinetriphosphate‏ ‎‡A Transient receptor potential cation channel, subfamily V, member 4 and airway sensory afferent activation: Role of adenosine triphosphate‏ ‎‡9 1‏
919 ‎‡a transientreceptorpotentialvanilloid1‏ ‎‡A Transient receptor potential vanilloid 1‏ ‎‡9 1‏
919 ‎‡a transientreceptorpotentialvanilloid1trpv1antagonisminpatientswithrefractorychroniccoughadoubleblindrandomizedcontrolledtrial‏ ‎‡A Transient receptor potential vanilloid 1 (TRPV1) antagonism in patients with refractory chronic cough: a double-blind randomized controlled trial.‏ ‎‡9 1‏
919 ‎‡a weakperistalsiswithlargebreaksinchroniccoughassociationwithpooresophagealclearance‏ ‎‡A Weak peristalsis with large breaks in chronic cough: association with poor esophageal clearance.‏ ‎‡9 1‏
919 ‎‡a xend0501anoveltrpv1antagonistdoesnotreducecoughinrefractorycoughpatients‏ ‎‡A XEN-D0501, a Novel TRPV1 Antagonist, Does Not Reduce Cough in Refractory Cough Patients.‏ ‎‡9 1‏
919 ‎‡a muscleactivationandsoundduringvoluntarysinglecoughsandcoughpealsinhealthyvolunteersinsightsintocoughintensity‏ ‎‡A Muscle activation and sound during voluntary single coughs and cough peals in healthy volunteers: Insights into cough intensity.‏ ‎‡9 1‏
919 ‎‡a coughfrequencyandpatternsofcoughincysticfibrosis‏ ‎‡A Cough frequency and patterns of cough in cystic fibrosis‏ ‎‡9 1‏
919 ‎‡a howtoquantifycoughingcorrelationswithqualityoflifeinchroniccough‏ ‎‡A How to quantify coughing: correlations with quality of life in chronic cough‏ ‎‡9 1‏
919 ‎‡a highfrequencytriazoleresistancefoundinnonculturableaspergillusfumigatusfromlungsofpatientswithchronicfungaldisease‏ ‎‡A High-frequency triazole resistance found In nonculturable Aspergillus fumigatus from lungs of patients with chronic fungal disease‏ ‎‡9 1‏
919 ‎‡a interruptingthecoughreflexinasthma‏ ‎‡A Interrupting the cough reflex in asthma‏ ‎‡9 1‏
919 ‎‡a gerdrelatedcoughpathophysiologyanddiagnosticapproach‏ ‎‡A GERD-related cough: pathophysiology and diagnostic approach.‏ ‎‡9 1‏
919 ‎‡a interventionsforcoughincancer‏ ‎‡A Interventions for cough in cancer‏ ‎‡9 1‏
919 ‎‡a gefapixantin2randomiseddoseescalationstudiesinchroniccough‏ ‎‡A Gefapixant in two randomised dose-escalation studies in chronic cough‏ ‎‡9 1‏
919 ‎‡a managementoftherespiratorydistresssymptomclusterinlungcancerarandomisedcontrolledfeasibilitytrial‏ ‎‡A Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial‏ ‎‡9 1‏
919 ‎‡a gastrooesophagealrefluxandcough‏ ‎‡A Gastro-oesophageal reflux and cough‏ ‎‡9 1‏
919 ‎‡a monitoringchroniccoughcurrentandfuturetechniques‏ ‎‡A Monitoring chronic cough: current and future techniques‏ ‎‡9 1‏
919 ‎‡a gabapentinforrefractorychroniccough‏ ‎‡A Gabapentin for refractory chronic cough‏ ‎‡9 1‏
919 ‎‡a morphologiccharacterizationofnervesinwholemountairwaybiopsies‏ ‎‡A Morphologic Characterization of Nerves in Whole-Mount Airway Biopsies‏ ‎‡9 1‏
919 ‎‡a expertopiniononthecoughhypersensitivitysyndromeinrespiratorymedicine‏ ‎‡A Expert opinion on the cough hypersensitivity syndrome in respiratory medicine.‏ ‎‡9 1‏
919 ‎‡a ersguidelinesontheassessmentofcough‏ ‎‡A ERS guidelines on the assessment of cough‏ ‎‡9 1‏
996 ‎‡2 CAOONL|ncf10288064‏
996 ‎‡2 NII|DA17772336‏
996 ‎‡2 ISNI|0000000064068881‏
996 ‎‡2 J9U|987007386073205171‏
996 ‎‡2 LC|no2013122975‏
996 ‎‡2 LC|no 99057244‏
996 ‎‡2 ISNI|0000000388638377‏
996 ‎‡2 ISNI|0000000050731566‏
996 ‎‡2 BIBSYS|90131477‏
996 ‎‡2 RERO|A012488324‏
996 ‎‡2 LC|nr 93020262‏
996 ‎‡2 ISNI|0000000066543498‏
996 ‎‡2 BIBSYS|12065939‏
996 ‎‡2 LC|n 88179691‏
996 ‎‡2 ISNI|0000000108021197‏
996 ‎‡2 PLWABN|9810561777905606‏
996 ‎‡2 BIBSYS|90234722‏
996 ‎‡2 LNB|LNC10-000103752‏
996 ‎‡2 ISNI|0000000068911848‏
996 ‎‡2 NLA|000035068372‏
996 ‎‡2 ISNI|0000000046630308‏
996 ‎‡2 RERO|A022871028‏
996 ‎‡2 NUKAT|n 2017182837‏
996 ‎‡2 CAOONL|ncf10127237‏
996 ‎‡2 ISNI|0000000366962344‏
996 ‎‡2 NTA|157415171‏
996 ‎‡2 ISNI|0000000053205908‏
996 ‎‡2 NUKAT|n 97081285‏
996 ‎‡2 LC|n 86031700‏
996 ‎‡2 NTA|339748494‏
996 ‎‡2 BIBSYS|97017404‏
996 ‎‡2 ISNI|0000000437210319‏
996 ‎‡2 CAOONL|ncf11609943‏
996 ‎‡2 LC|n 2007161955‏
996 ‎‡2 LC|n 89639641‏
996 ‎‡2 BIBSYS|98003933‏
996 ‎‡2 LC|no2009120943‏
996 ‎‡2 NTA|073267384‏
996 ‎‡2 NTA|078207959‏
996 ‎‡2 LC|no2016127959‏
996 ‎‡2 BIBSYS|90178954‏
996 ‎‡2 ISNI|0000000069412864‏
996 ‎‡2 LC|n 92074049‏
996 ‎‡2 W2Z|1669188157825‏
996 ‎‡2 ISNI|0000000109225968‏
996 ‎‡2 LC|no2017065488‏
996 ‎‡2 CAOONL|ncf11267686‏
996 ‎‡2 LC|nr 92041310‏
996 ‎‡2 NTA|071110844‏
996 ‎‡2 NSK|000644409‏
996 ‎‡2 LC|nb2007013542‏
996 ‎‡2 BNF|17893555‏
996 ‎‡2 DBC|87097969700292‏
996 ‎‡2 DNB|135399440‏
996 ‎‡2 ISNI|0000000083001703‏
996 ‎‡2 ISNI|0000000393699924‏
996 ‎‡2 NTA|243055102‏
996 ‎‡2 LC|n 86812463‏
996 ‎‡2 SUDOC|259392316‏
996 ‎‡2 SUDOC|032710550‏
996 ‎‡2 LC|nb2002049173‏
996 ‎‡2 ISNI|000000005236961X‏
996 ‎‡2 SUDOC|26271857X‏
996 ‎‡2 ISNI|0000000034856641‏
996 ‎‡2 NTA|108915328‏
996 ‎‡2 DE633|pe30004092‏
996 ‎‡2 CAOONL|ncf10049569‏
996 ‎‡2 DNB|171041895‏
996 ‎‡2 CAOONL|ncf10098279‏
996 ‎‡2 BIBSYS|15014406‏
996 ‎‡2 LC|n 2010160018‏
996 ‎‡2 DNB|1300468319‏
996 ‎‡2 SUDOC|200068210‏
996 ‎‡2 PLWABN|9810591197505606‏
996 ‎‡2 BLBNB|000357419‏
996 ‎‡2 LC|nb2017020885‏
996 ‎‡2 DNB|1053251661‏
996 ‎‡2 ISNI|0000000038628531‏
996 ‎‡2 ISNI|0000000083600482‏
996 ‎‡2 LC|no 90020835‏
996 ‎‡2 LC|n 98015959‏
996 ‎‡2 DBC|87097946266595‏
996 ‎‡2 NII|DA11431310‏
996 ‎‡2 ISNI|0000000029520262‏
996 ‎‡2 J9U|987007457707605171‏
996 ‎‡2 BNF|15108282‏
996 ‎‡2 DNB|1064966195‏
996 ‎‡2 ISNI|0000000031049035‏
996 ‎‡2 NII|DA08320865‏
996 ‎‡2 ISNI|0000000394125121‏
996 ‎‡2 NTA|069501254‏
996 ‎‡2 LC|n 82274675‏
996 ‎‡2 LC|no2009152477‏
996 ‎‡2 NTA|068897472‏
996 ‎‡2 LC|n 2005018023‏
996 ‎‡2 BIBSYS|90521810‏
996 ‎‡2 ISNI|0000000033348784‏
996 ‎‡2 LC|n 84184465‏
996 ‎‡2 PTBNP|232829‏
996 ‎‡2 LC|no2012059832‏
996 ‎‡2 RERO|A011962744‏
996 ‎‡2 ISNI|0000000075853877‏
996 ‎‡2 LC|nr 88002481‏
996 ‎‡2 LC|nb 98013488‏
996 ‎‡2 LC|nr 96042493‏
996 ‎‡2 ISNI|0000000419224514‏
996 ‎‡2 NII|DA05963836‏
996 ‎‡2 ISNI|0000000395521409‏
996 ‎‡2 NTA|157167062‏
996 ‎‡2 SUDOC|227529081‏
996 ‎‡2 NTA|114064504‏
996 ‎‡2 DNB|1057718599‏
996 ‎‡2 BIBSYS|1669188157825‏
996 ‎‡2 BNF|14964110‏
996 ‎‡2 DE633|pe30024801‏
996 ‎‡2 DNB|138789630‏
996 ‎‡2 DNB|130660868‏
996 ‎‡2 PTBNP|160742‏
996 ‎‡2 CAOONL|ncf11196861‏
996 ‎‡2 ISNI|0000000444394072‏
996 ‎‡2 NII|DA07773117‏
996 ‎‡2 DNB|127344756‏
996 ‎‡2 LC|n 83022107‏
996 ‎‡2 LC|nr 91033012‏
996 ‎‡2 LC|nb 91048526‏
996 ‎‡2 NTA|073138525‏
996 ‎‡2 DNB|104376260‏
996 ‎‡2 J9U|987007354009605171‏
996 ‎‡2 LC|no2013093220‏
996 ‎‡2 LC|n 79051192‏
996 ‎‡2 JPG|500019843‏
996 ‎‡2 LC|nb2003003208‏
996 ‎‡2 DNB|103753459X‏
996 ‎‡2 J9U|987012501079605171‏
996 ‎‡2 SUDOC|204204542‏
996 ‎‡2 N6I|vtls002420043‏
996 ‎‡2 SUDOC|189547073‏
996 ‎‡2 PTBNP|249257‏
996 ‎‡2 LC|nr 89004033‏
996 ‎‡2 NTA|097380369‏
996 ‎‡2 ISNI|0000000383196848‏
996 ‎‡2 LC|n 78028023‏
996 ‎‡2 LC|n 2008161793‏
996 ‎‡2 CAOONL|ncf10036477‏
996 ‎‡2 PLWABN|9811327417605606‏
996 ‎‡2 PTBNP|1592121‏
996 ‎‡2 JPG|500030541‏
996 ‎‡2 ISNI|0000000025584867‏
996 ‎‡2 LC|n 84239517‏
996 ‎‡2 NTA|157120473‏
996 ‎‡2 CAOONL|ncf10093197‏
996 ‎‡2 DNB|1089098375‏
996 ‎‡2 BNE|XX5266753‏
996 ‎‡2 BIBSYS|90745785‏
996 ‎‡2 ISNI|0000000023359316‏
996 ‎‡2 ISNI|0000000436061841‏
996 ‎‡2 BIBSYS|90529262‏
996 ‎‡2 W2Z|1581514959554‏
996 ‎‡2 NTA|320603016‏
996 ‎‡2 ISNI|0000000038807388‏
996 ‎‡2 BIBSYS|90637772‏
996 ‎‡2 J9U|987007434779405171‏
996 ‎‡2 NTA|123997704‏
996 ‎‡2 JPG|500033769‏
996 ‎‡2 ISNI|0000000498352193‏
996 ‎‡2 BIBSYS|90522326‏
996 ‎‡2 LC|n 2010061978‏
996 ‎‡2 LC|n 2014057987‏
996 ‎‡2 BIBSYS|90595474‏
996 ‎‡2 BNF|12457985‏
996 ‎‡2 LC|n 86140735‏
996 ‎‡2 NLA|000049863156‏
996 ‎‡2 BIBSYS|90232352‏
996 ‎‡2 LC|nb2019000318‏
996 ‎‡2 CAOONL|ncf11273329‏
996 ‎‡2 SUDOC|232639302‏
996 ‎‡2 DNB|1186816929‏
996 ‎‡2 NUKAT|n 2016160111‏
996 ‎‡2 NTA|113435215‏
996 ‎‡2 NSK|000094169‏
996 ‎‡2 LC|n 88279815‏
996 ‎‡2 NTA|304350117‏
996 ‎‡2 RERO|A003839389‏
996 ‎‡2 BIBSYS|90395090‏
996 ‎‡2 ISNI|0000000067494237‏
996 ‎‡2 SELIBR|265191‏
996 ‎‡2 NTA|072655305‏
996 ‎‡2 CAOONL|ncf11319362‏
996 ‎‡2 ISNI|0000000072626070‏
996 ‎‡2 BNF|14504718‏
996 ‎‡2 ISNI|0000000021247724‏
996 ‎‡2 LC|n 87858282‏
996 ‎‡2 ERRR|a12244168‏
996 ‎‡2 SUDOC|260169196‏
996 ‎‡2 LC|n 87813644‏
996 ‎‡2 NTA|105446939‏
996 ‎‡2 ISNI|0000000111216163‏
996 ‎‡2 JPG|500147607‏
996 ‎‡2 LC|n 85276081‏
996 ‎‡2 NII|DA12776577‏
996 ‎‡2 NTA|074908367‏
996 ‎‡2 LC|n 2023031982‏
996 ‎‡2 NSK|000066662‏
996 ‎‡2 LC|nb2006014830‏
996 ‎‡2 N6I|vtls000070802‏
996 ‎‡2 LC|no 00031633‏
996 ‎‡2 SUDOC|078075920‏
996 ‎‡2 BIBSYS|90524947‏
996 ‎‡2 NUKAT|n 2020202308‏
996 ‎‡2 ISNI|0000000389644613‏
996 ‎‡2 DNB|172140390‏
996 ‎‡2 BIBSYS|90110713‏
996 ‎‡2 RERO|A003839400‏
996 ‎‡2 RERO|A003839401‏
996 ‎‡2 RERO|A003839402‏
996 ‎‡2 NII|DA03696717‏
996 ‎‡2 LC|n 79144217‏
996 ‎‡2 LC|nb2004314174‏
996 ‎‡2 N6I|vtls000030028‏
996 ‎‡2 LC|n 2015000178‏
996 ‎‡2 BIBSYS|90289153‏
996 ‎‡2 LC|nb2010017792‏
996 ‎‡2 NTA|075138891‏
996 ‎‡2 ISNI|0000000014835034‏
996 ‎‡2 ISNI|0000000391539636‏
996 ‎‡2 DNB|122327861‏
996 ‎‡2 BIBSYS|90502014‏
996 ‎‡2 LC|nb2018000275‏
996 ‎‡2 NTA|236441272‏
996 ‎‡2 SUDOC|226990281‏
996 ‎‡2 BNF|12310371‏
996 ‎‡2 ISNI|0000000384327213‏
996 ‎‡2 J9U|987007327981505171‏
996 ‎‡2 PLWABN|9810646625305606‏
996 ‎‡2 BNCHL|10000000000000000170555‏
996 ‎‡2 CAOONL|ncf10017272‏
996 ‎‡2 NUKAT|n 2015169581‏
996 ‎‡2 BIBSYS|90057260‏
996 ‎‡2 SUDOC|197863876‏
996 ‎‡2 ISNI|0000000066645531‏
996 ‎‡2 NDL|00456940‏
996 ‎‡2 LC|n 2014046325‏
996 ‎‡2 ISNI|000000039031294X‏
996 ‎‡2 DNB|1112387501‏
996 ‎‡2 ISNI|0000000031514347‏
996 ‎‡2 BAV|495_284147‏
996 ‎‡2 LC|n 78007225‏
996 ‎‡2 DNB|1052515592‏
996 ‎‡2 ISNI|0000000078698593‏
996 ‎‡2 CAOONL|ncf10197573‏
997 ‎‡a 0 0 lived 0 0‏ ‎‡9 1‏